HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of 3,4-dihydroxyacetophenone on the hypercholesterolemia-induced atherosclerotic rabbits.

Abstract
3,4-Dihydroxyacetophenone (3,4-DHAP) is one herbal extract from bald Mao-dong-qing leaves. We reported that 3,4-DHAP had anti-inflammatory function by decreasing tumor necrosis factor-α (TNF-α) secretion in macrophages. The aim of the study was to examine the effects of 3,4-DHAP on plasma and liver lipids, plasma alanine aminotranferase (ALT) and TNF-α level, vascular cell adhesion molecule-1 (VCAM-1) expression, plaque vulnerability and vascular inflammation in hypercholesterolemia-induced atherosclerotic rabbits. Male New Zealand white rabbits were randomized into negative control, positive control, 3,4-DHAP and simvastatin groups. From weeks 2 to 12, the rabbits were treated with 3,4-DHAP or simvastatin. At weeks 12, all the animals were sacrificed. Plasma lipids and ALT were measured using the enzymatic endpoint method. Plasma TNF-α was measured using enzyme-linked immuno sorbent assay (ELISA). Liver lipids concentrations were estimated using commercial kits. The expression of VCAM-1 was measured using reverse transcription-polymerase chain reaction (RT-PCR) and Western blot. Histological analysis was used to evaluate the pathologic changes of rabbit aortas. The results showed that 3,4-DHAP markedly lowered plasma and liver lipids, lowered plasma ALT and TNF-α levels compared with the positive control group. VCAM-1 mRNA and protein were markedly inhibited by 3,4-DHAP. Decreased aortic plaque instability was evident in 3,4-DHAP-treated rabbits, as demonstrated by a thickened elastic layer, increased vascular smooth muscle cells (VSMCs) accumulation in the plaques, less neointima hyperplasia and macrophages recruitment. 3,4-DHAP may attenuate the progression of atherosclerotic lesions and stabilize plaques by lowering plasma lipids, the number of macrophages and the expression of VCAM-1, while increasing the number of VSMCs in the atherosclerotic plaques.
AuthorsDaijuan Zhang, Jiangyue Liu, Lin Wang, Jianying Wang, Wentao Li, Baoxiang Zhuang, Jianping Hou, Tongmei Liu
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 36 Issue 5 Pg. 733-40 ( 2013) ISSN: 1347-5215 [Electronic] Japan
PMID23412669 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetophenones
  • Anti-Inflammatory Agents
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Vascular Cell Adhesion Molecule-1
  • 3,4-dihydroxyacetophenone
  • Alanine Transaminase
Topics
  • Acetophenones (pharmacology)
  • Alanine Transaminase (blood)
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Aorta (pathology)
  • Atherosclerosis (etiology, metabolism, pathology)
  • Hypercholesterolemia (complications, metabolism, pathology)
  • Lipid Metabolism (drug effects)
  • Liver (drug effects, metabolism)
  • Macrophages (drug effects, metabolism)
  • Male
  • Muscle, Smooth, Vascular (pathology)
  • RNA, Messenger (metabolism)
  • Rabbits
  • Tumor Necrosis Factor-alpha (blood)
  • Vascular Cell Adhesion Molecule-1 (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: